Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells

被引:58
|
作者
Kikuchi, H
Iizuka, R
Sugiyama, S
Gon, G
Mori, H
Arai, M
Mizumoto, K
ImajohOhmi, S
机构
[1] UNIV TOKYO,INST MED SCI,MINATO KU,TOKYO 108,JAPAN
[2] KITASATO UNIV,SCH PHARMACEUT SCI,TOKYO 108,JAPAN
[3] JIKEI UNIV,SCH MED,TOKYO,JAPAN
[4] NATL INST AGROBIOL RESOURCES,IBARAKI,OSAKA,JAPAN
关键词
apoptosis; cell growth; cell death; Fas antigen; monocyte/macrophage;
D O I
10.1002/jlb.60.6.778
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferon-gamma (IFN-gamma), vitamin D-3 (VD), and retinoic acid (RA) induce differentiation of human monoblastic leukemia U937 cells to macrophage-like cells with potential superoxide anion-generating activity upon further stimulation. Here we report that U937 cells thus differentiated show various responses to apoptotic induction with a cytotoxic anti-Fas antibody and tumor necrosis factor (TNF), VD-or RA-treated U937 cells acquired resistance against Fas- or TNF receptor (TNFR)-mediated apoptosis, whereas apoptotic cell death was accelerated in IFN-gamma-treated cells, By flow cytometric analyses, no decrease in expression of surface Fas antigen or p55 TNFR was observed in differentiated U937 cells, Cell surface expression of CD11b was seen only when differentiation was induced with VD or RA but not with IFN-gamma, The growth of VD- or RA-treated cells was retarded but IFN-gamma-treated cells were prolific, These findings suggest that the differentiation state differs with the inducer and that the cellular response to apoptotic induction is closely related to the state including the cell cycle.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 50 条
  • [1] Tumor necrosis factor-alpha gene transfer augments anti-fas antibody-mediated apoptosis in human glioma cells
    Mizuno, M
    Yoshida, J
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (05): : 543 - 547
  • [2] INTERLEUKIN-6 REGULATES THE CYTOTOXIC EFFECT OF TUMOR-NECROSIS-FACTOR ON U937 CELLS
    CAIRNS, JA
    GUY, GR
    TAN, YH
    IMMUNOLOGY, 1992, 75 (04) : 669 - 673
  • [3] A RECESSIVE MUTANT OF THE U937 CELL-LINE ACQUIRED-RESISTANCE TO ANTI-FAS AND ANTI-P55 TUMOR-NECROSIS-FACTOR RECEPTOR ANTIBODY-INDUCED APOPTOSIS
    NOGUCHI, K
    NAITO, M
    KATAOKA, S
    YONEHARA, S
    TSURUO, T
    CELL GROWTH & DIFFERENTIATION, 1995, 6 (10): : 1271 - 1277
  • [4] 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis is mediated by tumor necrosis factor α in human monocytic U937 cells
    Takada, Y
    Hachiya, M
    Osawa, Y
    Hasegawa, Y
    Ando, K
    Kobayashi, Y
    Akashi, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (40) : 28286 - 28292
  • [5] 12-O-tetradecanoylphorbol-13-acetate-induced apoptosis is mediated by tumor necrosis factor α in human monocytic U937 cells
    Division of Radiation Health, Natl. Inst. of Radiological Sciences, Chiba, 263-8555, Japan
    不详
    不详
    不详
    不详
    J Biol Chem, 40 (28286-28292):
  • [6] Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-α-induced apoptosis
    Dong, J
    Naito, M
    Mashima, T
    Jang, WH
    Tsuruo, T
    JOURNAL OF CELLULAR PHYSIOLOGY, 1998, 174 (02) : 179 - 185
  • [7] TUMOR-NECROSIS-FACTOR-ALPHA INDUCES APOPTOSIS IN HIV-INFECTED U937 CELLS
    MALORNI, W
    RIVABENE, R
    RAINALDI, G
    SANTINI, MT
    DONELLI, G
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 1995, 14 (01) : 118 - 119
  • [8] Endogenously produced nitric oxide increases tumor necrosis factor-alpha production in transfected human U937 cells
    Yan, L
    Wang, SB
    Rafferty, SP
    Wesley, RA
    Danner, RL
    BLOOD, 1997, 90 (03) : 1160 - 1167
  • [9] Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor
    Yano, M
    Kishida, E
    Iwasaki, M
    Kojo, S
    Masuzawa, Y
    JOURNAL OF NUTRITION, 2000, 130 (05): : 1095 - 1101
  • [10] Dynamics of apoptotic events induced in human leukemia U-937 cells by tumor necrosis factor
    Kudryavets, YI
    Phylchenkov, AA
    Abramenko, IV
    Polischouk, LZ
    Slukvin, II
    Belous, NI
    EXPERIMENTAL ONCOLOGY, 1996, 18 (04): : 353 - 365